Belgian biotech Agomab Therapeutics and eye-focused drug delivery company SpyGlass Pharma both headed to the Nasdaq this ...
The new release reflects a growing demand for enterprise AI approaches that prioritize strong data foundations, ...
SpyGlass Pharma Inc. shares jumped 65% in the biopharmaceutical firm’s trading debut after it raised $150 million in an ...
US ophthalmology company SpyGlass Pharma has set out the terms of an initial public offering (IPO) in which the firms hopes to raise in excess of $150 million.
Now up for sale: a popular winery and concert venue in Northumberland County. The owners of Spyglass on the Ridge near ...
Agomab Therapeutics and SpyGlass Pharma secured a combined $350 million in two separate initial public offerings on Thursday ...
9don MSN
Who Owns the ‘Ghostface' Mask? Paramount and Spyglass Sue to Find Out Ahead of ‘Scream 7' Release
The companies filed a lawsuit against a special effects studio, which has threatened to initiate litigation over rights to ...
A privately held ophthalmic company headquartered in Southern California (Aliso Viejo). The company’s development work is ...
The SpyGlass Pharma platform, a novel, non-bioerodible drug delivery technology, is designed to be used with various well-established, approved medicines, including bimatoprost and other small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results